-+ 0.00%
-+ 0.00%
-+ 0.00%

LYTIX BIOPHARMA: FDA ALSO CONFIRMED THAT A SINGLE WELL-CONTROLLED TRIAL MAY SUPPORT A NEW DRUG APPLICATION FOR LTX-315

Reuters·08/27/2026 04:58:40

Please log in to view news